In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Alexander Wallroth

 

Latest From Alexander Wallroth

2023-2024 Global Biopharma R&D Productivity And Growth Ranking

Bookmark
  • Analysis
By Markus Thunecke, Erika Kuchen and Alexander Wallroth

The overall R&D productivity of the 30 largest public biopharma companies has increased despite a challenging global environment for investment and growth. Will hype cycles impact this picture in coming years?

Market Intelligence Commercial

2022 Global Biopharma R&D Productivity And Growth Ranking

Bookmark
  • Analysis
By Markus Thunecke, Erika Kuchen and Alexander Wallroth

The R&D productivity of the top 30 largest biopharma companies decreased slightly from 2021 to 2022 and the sector saw the lowest number of FDA approvals in the past 10 years. 

Sustainability Research & Development
See All
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By